_Save the Date Women's Symposium
cfar
hiv students in africa
slide 3
slide 4
slide 5
slide1
slide2
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Center for AIDS Research

The Einstein-Montefiore Center for AIDS Research

CFAR Logo

The Einstein-Montefiore Center for AIDS Research (CFAR) coordinates, stimulates and supports the multidisciplinary research activities of over 120 NIH-funded faculty investigators at the Albert Einstein College of Medicine (Einstein) and Montefiore Medical Center (Montefiore). Our CFAR plays a crucial role in enabling our investigators to uncover new mechanisms by which HIV-1 infects cells and causes disease and to translate these discoveries into new therapies, approaches and interventions to improve the treatment of HIV-1-infected individuals prevent the further spread of HIV-1 infection. This translational research is particularly relevant to members of our community which includes nearly 15,000 HIV-infected men and women infected with HIV-1, more than 90% Latino or African American as well as our affiliated international sites located in areas where HIV infection is endemic.

 

CFAR Educational, Mentoring and Research Support Activities

Einstein-Montefiore CFAR AIDS Club
Rodney L. Wright, MD
Associate Professor of Clinical Obstetrics & Gynecology and Women's Health
CD4+ and CD8+ T-Cell Trajectories During Pregnancy in HIV-infected Women
Friday, May 23rd, Price 451, 9AM 

For a complete calendar of all the CFAR organized seminars please click here.

  

The Developmental Core provides a wide array of structured programs to provide research mentoring to early stage investigators and investigators interested in expanding their research programs to HIV/AIDS-related research. All basic science, translational and clinical CFAR investigators can access these programs.

To initiate the mentoring process, please fill out the Einstein-Montefiore CFAR Individual Developmental Plan (click here to download) and email Dr. Prasad of Dr. Arnsten.

The University of Wisconsin Institute for Clinical and Translational research hosts a website (click here) that provides resources to improve research mentoring relationships. It provides curricula, assessment tools and resources relevant for mentors and mentees, as well as those who would like to implement mentor training. 

 



 

RFA-AI-14-021: Targeting Latently Infected Cells Without Reactivation (R01). Application Due Date July 15, 2014
 

PA-14-134:Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care (R21). Application Due Date:May 25, 2014 and September 25, 2014.

PA-14-133:Advancing Structural Level Intervention Through Enhanced Understanding of Social Determinants in HIV Prevention and Care (R01). Application Due Date: May 25, 2014 and September 25, 2014.

PA-14-132:Accelerating Improvements in the HIV Care Continuum (R01). Application Due Date: May 25, 2014 and September 25, 2014.

PA-14-131:Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research (R01). Application Due Date: May 25, 2014 and September 25, 2014.

PA-14-130: Accelerating Improvements in the HIV Care Continuum (R21). Application Due Date: May 25, 2014 and September 25, 2014.

PA-14-129: Improving Delivery of HIV Prevention and Treatment through Implementation Science and Transnational Research (R21). Application Due Date: May 25, 2014 and September 25, 2014.

PA-14-128: Targeted Basic Behavioral and Social Science and Intervention Development for HIV Prevention and Core (R21). Application Due Date: May 25, 2014 and September 25, 2014.

PA-14-127: Targeted Basic Behavioral and Social Science and Intervention Development for HIV Prevention and Care (R01). Application Due Date: May 25, 2014 and September 25, 2014.

PA-14-126: Strengthening Adherence to Antiretroviral-Based HIV Prevention and Treatment (R01). Application Due Date: May 25, 2014 and September 25, 2014.

PA-14-125: Strengthening Adherence to Antiretroviral-Based HIV Treatment and Prevention (R21). Application Due Date: May 25, 2014 and September 25, 2014.

RFA-AI-13-055: Pilot Clinical Trials to Eliminate the Latent HIV Reservoir (U01). Application Due Date: July 15, 2014.

RFA-AI-14-008:Sustained Release for Antiretroviral Treatment of Presention (SRATP) of HIV Infection (UM1).Application Due Date: November 18, 2014
RFA-HL-14-023: Clinical Research in the Prevention, Diagnosis, and Treatment of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01). Application Due Dates: May 8, 2014; September 9, 2014; and January 8, 2015.

RFA-HL-14-024: Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01/R21). Application Due Dates: May 8, 2014; September 9, 2014; and January 8, 2015.

PA-14-214: HIV Vaccine Vector-Host Interactions: Understanding the Biology and Immunology (R21):Application Due Dates: Standard AIDS and AIDS-related dates, May 7, September 7 & January 7

PA-14-215: HIV Vaccine Vector-Host Interaction: Understanding the Biology and Immunology (R01):Standard AIDS and AIDS-related dates, May 7, September 7 & January 7

PA-14-216: B Cell Help Immunology Program for AIDS Vaccine Strategies (R01): Standard AIDS and AIDS-related date, May 7, September 7 & January 7

PA-14-217: NK Cells to Induced Immunological Memory to Prevent HIV Infection (R01):Standard AIDS and AIDS-related date, May 7, September 7 & January 7

PA-14-218: Fc Receptor (FCR) and Antibody Effector Function in HIV Vaccine Discovery (R01):Standard AIDS and AIDS-related date, May 7, September 7 & January 7

PA-13-377: Research on Malignancies in the Context of HIV/AIDS (R01/R21). Application Due Dates: May 8, 2014; September 9, 2014; and January 8, 2015.

PAR -13-349: Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01). Application Due Dates: January 8, 2015; January 8, 2016.

PAR-13-267: Novel NeuroAIDS Therapeutics: Integrated Preclinical/Clinical Program (P01). Application Due Dates: January 8, 2015; January 8, 2016.

 

Please click here for further information.

The HIV Integrated Clinical Database (HICDB) provides access to the full array of clinical data for ~15,000 HIV+ and 217,000 HIV-negative patients.  [For a demo of the database using screen captures, please click here. Username:dbmu\cfar and Password: cfar and click the red boxes.] For an example demonstrating how this database was used to obtain data for a study investigating the impact of population-based HIV treatment and adherence initiatives in the Bronx implemented in the past 6 years on control of HIV infection in the Bronx, please click here for a PowerPoint presentation of the data and analysis. The HIV Integrated Research Database (HIRDB) with Virtual Biorepository centralizes data from HIV+ research participants (and HIV-negative controls) and available specimens in the repositories maintained for Einstein CFAR investigators’ funded research. Please contact Dr. Kathy Anastos for login information to access the HICDB and HIRDB.
 

 
 

CFAR Web-based Clinical Research Informatics System

To facilitate clinical and translation research by CFAR investigators the Clinical and Translational Investigation Core (CTIC) has established unified web-based clinical research databases that combines data from diverse cohorts and specimen repositories into one centralized relational database.The HIV Integrated Research Database (HIRDB) with Virtual Biorepository centralizes data from HIV+ research participants (and HIV-negative controls) in Einstein to provide CFAR members with access to a broad-based Biobank derived from “remainder” specimens, including tissue. The HIV Integrated Clinical Database (HICDB) provides access to the full array of clinical data for ~15,000 HIV+ and 217,000 HIV-negative patients. 

For a demo of the database using screen captures, please click here. Username:dbmu\cfar and Password: cfar and click the red boxes. 

CFAR Informatics CommonsDemographic distribution 

 

The CFAR HICDB and HIRDB are housed within the Einstein-Montefiore Centralized Informatics Commons, as conceptualized in the above Figure on the left, which centralizes and integrates data from all clinically and biologically relevant sources within their joint facilities. An example of results of an HICDB query to identify HIV-infected patients > 60 years of age by gender and demographic distributions is shown in the above Figure (on the right). For information about accessing the Databases and a demo of a query focused on correlating medications with viral load, please click here to link to the Clinical and Translational Core. 

 
 

 

 

 

CFAR News

In FY 13 , CFAR Investigators were awarded over $10m in new HIV/AIDS related grants including the WIHS grant renewal. For details please click here.

Two new pilot projects funding HIV/AIDS malignancy research were recently awarded to two CFAR investigators, Drs. Mark Einstein and Howard Strickler from an NCI supplement to the Cancer Center.

  The Wall Street Journal  interviews Dr. Max O'Donnell for a front-page story on TB "hotbed" that developed in a South African Prison.

CFAR investigators Drs. Betsy Herold and Marla Keller have been awarded $12 million grant to develop a device for preventing HIV infection.

  more news 

 

 

 

 

Meet Our Investigators

Dr. Duncan Wilson

Assembly and Function of the Herpes simplex Envelope

Herpes viruses are associated with a wide range of diseases; Burkitts lymphoma and nasopharyngeal carcinoma (Epstein-Barr virus), cytomegalic inclusion disease (Cytomegalovirus), chickenpox and shingles ...View profile

 

CFAR in Einstein Publications

History of Einstein AIDS Research



Read the Publication View online magazine
 

TB and HIV




Read the Publication View online magazine
 
 
 
 
Click here to log in